NDC 10135-738 – Rifabutin
Rifabutin 150 mg/1 · Capsule · Oral
Product NDC10135-738
Product details
- Brand name
- Rifabutin
- Generic name
- Rifabutin
- Labeler
- Marlex Pharmaceuticals, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA215041
- Marketed since
- May 1, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Rifamycin Antimycobacterial
Active ingredients
- Rifabutin 150 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 10135-738-01 | 100 CAPSULE in 1 BOTTLE (10135-738-01) | May 1, 2022 |
Other Rifabutin products
- 73141-020 Rifabutin 150 mg/1 · Capsule · A2A Integrated Pharmaceuticals
- 70954-041 Rifabutin 150 mg/1 · Capsule · ANI Pharmaceuticals, Inc.
- 72319-010 Rifabutin 150 mg/1 · Capsule · i3 Pharmaceuticals, LLC
- 59762-1350 Rifabutin 150 mg/1 · Capsule · Mylan Pharmaceuticals Inc.
- 70518-4254 Rifabutin 150 mg/1 · Capsule · REMEDYREPACK INC.
- 70518-4594 Rifabutin 150 mg/1 · Capsule · REMEDYREPACK INC.